Andreas Wicki, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 258,816 shares at $60.01 ($15.2M) on 2022-11-08, disclosed to the SEC on 2022-11-10.
Open-market sale of $15.2M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.01 | 18,865 | $1.1M | 7.4% |
| 2 | $60.01 | 18,865 | $1.1M | 7.4% |
| 3 | $58.05 | 15,301 | $888K | 5.8% |
| 4 | $58.05 | 15,301 | $888K | 5.8% |
| 5 | $58.80 | 95,242 | $5.6M | 36.7% |
| 6 | $58.80 | 95,242 |
| $5.6M |
| 36.7% |
| Total | $58.89 avg | 258,816 | $15.2M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |
| HRMY | SELL | 2022-08-10 | $62.2M | — | Filing → |